 Connection
Kevin Ess to Sirolimus
This is a "connection" page, showing publications Kevin Ess has written about Sirolimus.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.108 |
|
|
|
-
Ess KC, Roach ES. New therapies for tuber-less sclerosis: white matter matters? Neurology. 2012 Feb 21; 78(8):520-1.
Score: 0.359
-
Carson RP, Van Nielen DL, Winzenburger PA, Ess KC. Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Neurobiol Dis. 2012 Jan; 45(1):369-80.
Score: 0.349
-
Krueger DA, Capal JK, Curatolo P, Devinsky O, Ess K, Tzadok M, Koenig MK, Narayanan V, Ramos F, Jozwiak S, de Vries P, Jansen AC, Wong M, Mowat D, Lawson J, Bruns S, Franz DN. Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience. Eur J Paediatr Neurol. 2018 Nov; 22(6):1066-1073.
Score: 0.141
-
Kim SH, Kowalski ML, Carson RP, Bridges LR, Ess KC. Heterozygous inactivation of tsc2 enhances tumorigenesis in p53 mutant zebrafish. Dis Model Mech. 2013 Jul; 6(4):925-33.
Score: 0.098
-
Kim SH, Speirs CK, Solnica-Krezel L, Ess KC. Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cell-autonomous functions of mutant tuberin. Dis Model Mech. 2011 Mar; 4(2):255-67.
Score: 0.082
-
Ess KC. Tuberous sclerosis complex: a brave new world? Curr Opin Neurol. 2010 Apr; 23(2):189-93.
Score: 0.079
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|